An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection
Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplif...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/180529 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-180529 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1805292024-10-13T15:37:47Z An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection Sun, Yan Zhang, Kaixi Santos, May Delos Pee, Carmen J. E. Yang, Yanmeng Kang, Meiqi Shin, Sung Jae Chan-Park, Mary B. Pethe, Kevin Lee Kong Chian School of Medicine (LKCMedicine) School of Chemistry, Chemical Engineering and Biotechnology Interdisciplinary Graduate School (IGS) Singapore-MIT Alliance for Research and Technology Centre National Centre for Infectious Diseases, Singapore Centre for Antimicrobial Bioengineering Singapore Centre for Environmental Life Sciences and Engineering (SCELSE) Medicine, Health and Life Sciences Mouse model Lung infection Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplified immunosuppressed mouse model using only four injections of cyclophosphamide, which allows for sustained M. abscessus lung burden for up to 16 days. This model proved effective for antibiotic efficacy evaluation, as demonstrated with imipenem or amikacin. Ministry of Education (MOE) National Research Foundation (NRF) Published version This research was supported in part by the Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 3 (Grant MOE2018- T3-1-003), by a MOE Tier 1 (Grant RT01/20), by the National Research Foundation (NRF) Singapore under its Investigatorship Program (grant NRF-NRFI06-2020-0004), and under its Campus for Research Excellence and Technological Enterprise (CREATE) programme through the SMART AMR IRG. 2024-10-10T02:54:27Z 2024-10-10T02:54:27Z 2024 Journal Article Sun, Y., Zhang, K., Santos, M. D., Pee, C. J. E., Yang, Y., Kang, M., Shin, S. J., Chan-Park, M. B. & Pethe, K. (2024). An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection. Antimicrobial Agents and Chemotherapy, 68(8). https://dx.doi.org/10.1128/aac.01520-23 0066-4804 https://hdl.handle.net/10356/180529 10.1128/aac.01520-23 68 2-s2.0-85200938507 8 68 en MOE2018-T3-1-003 RT01/20 NRF-NRFI06-2020-0004 Antimicrobial Agents and Chemotherapy © 2024 American Society for Microbiology. All rights reserved. This article may be downloaded for personal use only. Any other use requires prior permission of the copyright holder. The Version of Record is available online at http://doi.org/10.1128/aac.01520-23 application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Medicine, Health and Life Sciences Mouse model Lung infection |
spellingShingle |
Medicine, Health and Life Sciences Mouse model Lung infection Sun, Yan Zhang, Kaixi Santos, May Delos Pee, Carmen J. E. Yang, Yanmeng Kang, Meiqi Shin, Sung Jae Chan-Park, Mary B. Pethe, Kevin An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection |
description |
Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplified immunosuppressed mouse model using only four injections of cyclophosphamide, which allows for sustained M. abscessus lung burden for up to 16 days. This model proved effective for antibiotic efficacy evaluation, as demonstrated with imipenem or amikacin. |
author2 |
Lee Kong Chian School of Medicine (LKCMedicine) |
author_facet |
Lee Kong Chian School of Medicine (LKCMedicine) Sun, Yan Zhang, Kaixi Santos, May Delos Pee, Carmen J. E. Yang, Yanmeng Kang, Meiqi Shin, Sung Jae Chan-Park, Mary B. Pethe, Kevin |
format |
Article |
author |
Sun, Yan Zhang, Kaixi Santos, May Delos Pee, Carmen J. E. Yang, Yanmeng Kang, Meiqi Shin, Sung Jae Chan-Park, Mary B. Pethe, Kevin |
author_sort |
Sun, Yan |
title |
An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection |
title_short |
An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection |
title_full |
An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection |
title_fullStr |
An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection |
title_full_unstemmed |
An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection |
title_sort |
optimized cyclophosphamide-treated mouse model of mycobacterium abscessus pulmonary infection |
publishDate |
2024 |
url |
https://hdl.handle.net/10356/180529 |
_version_ |
1814777704582479872 |